from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2100/-

LFCtreatmentdescriptionclass of inhibitor

-0.438

Amikacinug/mL Amikacintranslation

-0.131

Cap5-10ug/mL Capreomycintranslation

-0.210

Rox10-50 ug/mL Roxithromycintranslation

-0.859

SM2-5 ug/mL Streptomycintranslation

0.354

Tet5-10 ug/mL Tetracyclinetranslation

0.095

Rif0.2-5ug/mL Rifampicintranscription

-0.089

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.125

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.189

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.050

CPZ10-50 ug/mL Chlorpromazinerespiration

1.074

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.215

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.605

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.861

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.708

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.551

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.138

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.400

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.986

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.202

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.351

KCN5-20 ug/mL Potassium cyaniderespiration

-1.025

NaN30.2-2 mM Sodium aziderespiration

0.153

Nigericin50 uM Nigericinrespiration

-0.300

TRC10-150 ug/mL Triclosanrespiration

-0.979

TRZ10-25 ug/mL Thioridazinerespiration

-0.081

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

-0.471

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.323

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.050

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.532

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.747

NRP_1Non-replicating persistence stage 1dosRassociated

-0.221

Amp0.2mg/mL AmpicillincellWall

-0.361

Cephalexin20-100 ug/mL CephalexincellWall

0.025

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.393

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.397

EMB10-20 ug/mL EthambutolcellWall

-0.117

Eta12-40 ug/mL EthionamidecellWall

-0.057

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.576

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.716

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.675

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.145

BZA0.12 mg/mL BenzamidearomaticAmides

-0.151

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.128

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.068

H2O24 mM hydrogen peroxideDNAdamaging

2.540

Levo10 ug/mL LevofloxacinDNAdamaging

1.170

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.505

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.689

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.988

UVUV-irradiationDNAdamaging

-0.327

ARP41-4 ug/mL Antitubercular compound ARP4?

0.279

Antimycin12.5-50 ug/mL Antimycin A?

-0.280

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.187

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.291

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.875

PA8240.2-2 ug/mL PA-824?

-0.168

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.319

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.456

Verapamil50 uM Verapamil?

-0.285

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.170

methoxatin10-20 ug/mL Methoxatin?